3D生物打印
脚手架
脊髓损伤
再生(生物学)
再生医学
组织工程
脊髓
生物医学工程
医学
干细胞
生物
遗传学
细胞生物学
精神科
作者
Jingwei Jiu,Xuelong Li,Dijun Li,Jiarong Li,Lu Liu,Wenjie Yang,Lei Yan,Songyan Li,Jing Zhang,Xiaoke Li,Jiao Jiao Li,Bin Wang
出处
期刊:Biofabrication
[IOP Publishing]
日期:2024-04-03
卷期号:16 (3): 032003-032003
被引量:3
标识
DOI:10.1088/1758-5090/ad3a13
摘要
Abstract Regenerative healing of spinal cord injury (SCI) poses an ongoing medical challenge by causing persistent neurological impairment and a significant socioeconomic burden. The complexity of spinal cord tissue presents hurdles to successful regeneration following injury, due to the difficulty of forming a biomimetic structure that faithfully replicates native tissue using conventional tissue engineering scaffolds. 3D bioprinting is a rapidly evolving technology with unmatched potential to create 3D biological tissues with complicated and hierarchical structure and composition. With the addition of biological additives such as cells and biomolecules, 3D bioprinting can fabricate preclinical implants, tissue or organ-like constructs, and in vitro models through precise control over the deposition of biomaterials and other building blocks. This review highlights the characteristics and advantages of 3D bioprinting for scaffold fabrication to enable SCI repair, including bottom–up manufacturing, mechanical customization, and spatial heterogeneity. This review also critically discusses the impact of various fabrication parameters on the efficacy of spinal cord repair using 3D bioprinted scaffolds, including the choice of printing method, scaffold shape, biomaterials, and biological supplements such as cells and growth factors. High-quality preclinical studies are required to accelerate the translation of 3D bioprinting into clinical practice for spinal cord repair. Meanwhile, other technological advances will continue to improve the regenerative capability of bioprinted scaffolds, such as the incorporation of nanoscale biological particles and the development of 4D printing.
科研通智能强力驱动
Strongly Powered by AbleSci AI